Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Accounts Payables: 2020-2024

Historic Accounts Payables for Journey Medical (DERM) over the last 5 years, with Dec 2024 value amounting to $16.1 million.

  • Journey Medical's Accounts Payables fell 24.66% to $11.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.6 million, marking a year-over-year decrease of 24.66%. This contributed to the annual value of $16.1 million for FY2024, which is 11.57% down from last year.
  • Per Journey Medical's latest filing, its Accounts Payables stood at $16.1 million for FY2024, which was down 11.57% from $18.1 million recorded in FY2023.
  • Over the past 5 years, Journey Medical's Accounts Payables peaked at $36.6 million during FY2022, and registered a low of $1.8 million during FY2020.
  • For the 3-year period, Journey Medical's Accounts Payables averaged around $23.6 million, with its median value being $18.1 million (2023).
  • As far as peak fluctuations go, Journey Medical's Accounts Payables soared by 1,140.46% in 2021, and later tumbled by 50.37% in 2023.
  • Over the past 5 years, Journey Medical's Accounts Payables (MRY) stood at $1.8 million in 2020, then soared by 1,140.46% to $22.8 million in 2021, then surged by 60.31% to $36.6 million in 2022, then tumbled by 50.37% to $18.1 million in 2023, then fell by 11.57% to $16.1 million in 2024.
  • Its Accounts Payables was $16.1 million in FY2024, compared to $18.1 million in FY2023 and $36.6 million in FY2022.